MedPath

Post-marketing clinical study on milnacipran hydrochloride

Phase 4
Conditions
Depression, depressive states
Registration Number
JPRN-jRCT1080220060
Lead Sponsor
ASAHIKASEI PHARMA CORPORATIO
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Sex
All
Target Recruitment
Not specified
Inclusion Criteria

Inclusion criteria
1)male or female patients aged 20 to 64 years;
2)patients who have been diagnosed with DSM-4 depressive disorders , etc.
Exclusion criteria
1)patients with ischuria (such as prostatic disorders);
2)patients with glaucoma, etc.

Exclusion Criteria

Not provided

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Efficacy, safety
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath